Cepharanthine ( DrugBank: Cepharanthine )
1 disease
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 53 | シェーグレン症候群 | 1 |
53. シェーグレン症候群
臨床試験数 : 305 / 薬物数 : 325 - (DrugBank : 104) / 標的遺伝子数 : 58 - 標的パスウェイ数 : 188
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | JPRN-jRCTs061180072 | 11/08/2011 | 19/03/2019 | Cepharanthine trial | Clinicopathological study on the efficacy of Cepharanthine for preventing salivary gland destruction in Sjogren's syndrome patients - Cepharanthine trial | SjS | Cepharanthine (6 mg / day) administration | Yamanoi Tomoko | NULL | Complete | >= 20age old | Not applicable | Both | 25 | Phase 2-3 | Japan |